Conquering Diseases

Study Of Whether An Investigational Drug Is Safe And Effective For Non-Segmental Vitiligo


Seeking men and women aged 18-65 with non-segmental vitiligo for a study of an investigational drug.


Participants in this study will be randomly assigned to receive either the investigational drug or a placebo (looks like the drug but contains no medicine) during the first part of the study. In the second part of the study all participants will receive the investigational drug.

What we're hoping for

We are studying whether a drug that has been approved for other

Additional Information Identifier: NCT04927975

 Principal Investigator

Mehdi  Rashighi Firoozabadi, MD

UMass Memorial Health Care

 Study Contact

Dermatology  Research



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655